Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG)
- Conditions
- Primary Open-Angle Glaucoma (POAG)
- Interventions
- Other: Placebo
- First Posted Date
- 2025-03-30
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Pharmasoft
- Target Recruit Count
- 102
- Registration Number
- NCT06903156
- Locations
- 🇷🇺
Kirov Regional State Budgetary Healthcare Institution "Kirov Clinical Ophthalmological Hospital", Kirov, Russian Federation
🇷🇺Budgetary healthcare institution of the Omsk region "V.P. Vyhodtsev Clinical Ophthalmological Hospital", Omsk, Russian Federation
🇷🇺State Budgetary Institution of Healthcare of the Yaroslavl Region "Clinical Hospital No. 2", Yaroslavl, Russian Federation
Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12
- Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)Anxiety Disorders and Symptoms
- Interventions
- First Posted Date
- 2025-03-03
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Pharmasoft
- Target Recruit Count
- 333
- Registration Number
- NCT06854601
- Locations
- 🇷🇺
State Autonomous Healthcare Institution of the Sverdlovsk Region "Multispecialty Clinical Medical Center 'Bonum', Yekaterinburg, Ural region, Russian Federation
🇷🇺Federal State Budgetary Educational Institution of Higher Education "Kazan State Medical University" Ministry of Health of the Russian Federation, Kazan, Russian Federation
🇷🇺State Budgetary Healthcare Institution "Specialized Clinical Psychiatric Hospital №1" of the Ministry of Health of the Krasnodar Territory, Krasnodar, Russian Federation
Safety and Efficacy of Sequential Treatment with Mexidol® in Patients with Chronic Cerebral Ischemia
- First Posted Date
- 2025-02-19
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Pharmasoft
- Target Recruit Count
- 318
- Registration Number
- NCT06834490
- Locations
- 🇷🇺
Private Healthcare Institution "Clinical Hospital "RR-Medicine" of Voronezh, Voronezh, Russian Federation
🇷🇺OOO "Centre for Evidence-Based Medicine", Yaroslavl, Russian Federation
🇷🇺State Budget Healthcare Institution of the Yaroslavl Region "Clinical Hospital No.2", Yaroslavl, Russian Federation
MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG)
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Pharmasoft
- Target Recruit Count
- 80
- Registration Number
- NCT06437639
- Locations
- 🇷🇺
Tyumen Scientific Center of the Russian Academy of Sciences, Tyumen, Russian Federation
The Study of Efficacy and Safety of Mexidol® in Stroke Therapy (MIR)
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Pharmasoft
- Target Recruit Count
- 304
- Registration Number
- NCT06437626
- Locations
- 🇷🇺
Tatarstan Republican Clinical Hospital, Kazan, Russian Federation
🇷🇺Russian National Research Medical University n.a. N. I. Pirogov, Moscow, Russian Federation
🇷🇺Kazan City Hospital № 7, Kazan, Russian Federation
MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure
- First Posted Date
- 2024-01-24
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Pharmasoft
- Target Recruit Count
- 60
- Registration Number
- NCT06221826
- Locations
- 🇷🇺
Brain Institute Clinic, Ekaterinburg, Sverdlovsk Region, Russian Federation
Study of Efficacy and Safety of MEXIDOL® in Ischemic Stroke Therapy
- First Posted Date
- 2016-06-08
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Pharmasoft
- Target Recruit Count
- 150
- Registration Number
- NCT02793687
- Locations
- 🇷🇺
Tatarstan Republican Clinical Hospital, Kazan, Russian Federation
🇷🇺Interregional Clinical Diagnostic Center, Kazan, Russian Federation
🇷🇺Kazan Clinical Hospital № 7, Kazan, Russian Federation